As of tomorrow, two new medical conditions will be eligible to be treated with medical marijuana through Pennsylvania’s medical marijuana program.
Based on the recommendation of the state’s Medical Marijuana Advisory Board and a review of medical research, anxiety disorders and Tourette syndrome have been designated serious medical conditions.
“I have conducted a very careful review of the literature available about these conditions, and I have decided that I will this recommendation no later than July 20th,” Dr. Rachel Levine, Pennsylvania Department of Health secretary, said.
In addition to helping those dealing with these conditions, this move will allow for additional research into the effects of medical marijuana and perhaps lead to greater advancements in the future.
“We hope to learn more about all the approved medical conditions in the medical marijuana program,” Levine said. “And really a key component in approving conditions is to stimulate research on medical marijuana with those positions.”
Nearly 111,000 patients have already been approved to use medical marijuana through this program. Visit the PA Department of Health website or on social media for more information.